Neuroimaging of epilepsy, movement disorders, and degenerative diseases

D. L. Murman, K. A. Frey

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Neuroimaging has improved the understanding, diagnosis, and management of several neurologic diseases and syndromes. Recent advances in the neuroimaging of epilepsy, movement disorders, and degenerative diseases of the nervous system are reviewed. Current research confirms that structural and functional neuroimages each provide unique, clinically useful information in these disorders. Quantification of images improves their diagnostic sensitivity and specificity. Presymptomatic or early neurochemical changes have been identified and followed longitudinally in several neurodegenerative diseases, providing a method for monitoring response to therapeutic intervention and pathophysiologic hypothesis testing. Functional activation studies and receptor-specific radioligands continue to advance our understanding of these disorders. Future methods will take increasing advantage of both the ability to measure neuropharmacological and neurochemical changes in vivo, and the ability to combine images and information obtained with distinct structural and functional neuroimaging modalities.

Original languageEnglish (US)
Pages (from-to)919-926
Number of pages8
JournalCurrent Opinion in Neurology
Volume6
Issue number6
DOIs
StatePublished - Jan 1 1993

Fingerprint

Movement Disorders
Neuroimaging
Neurodegenerative Diseases
Epilepsy
Functional Neuroimaging
Nervous System Diseases
Sensitivity and Specificity
Research
Therapeutics

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Neuroimaging of epilepsy, movement disorders, and degenerative diseases. / Murman, D. L.; Frey, K. A.

In: Current Opinion in Neurology, Vol. 6, No. 6, 01.01.1993, p. 919-926.

Research output: Contribution to journalReview article

@article{c3c35f7548a04317b8d1fa3faaf29a01,
title = "Neuroimaging of epilepsy, movement disorders, and degenerative diseases",
abstract = "Neuroimaging has improved the understanding, diagnosis, and management of several neurologic diseases and syndromes. Recent advances in the neuroimaging of epilepsy, movement disorders, and degenerative diseases of the nervous system are reviewed. Current research confirms that structural and functional neuroimages each provide unique, clinically useful information in these disorders. Quantification of images improves their diagnostic sensitivity and specificity. Presymptomatic or early neurochemical changes have been identified and followed longitudinally in several neurodegenerative diseases, providing a method for monitoring response to therapeutic intervention and pathophysiologic hypothesis testing. Functional activation studies and receptor-specific radioligands continue to advance our understanding of these disorders. Future methods will take increasing advantage of both the ability to measure neuropharmacological and neurochemical changes in vivo, and the ability to combine images and information obtained with distinct structural and functional neuroimaging modalities.",
author = "Murman, {D. L.} and Frey, {K. A.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1097/00019052-199312000-00015",
language = "English (US)",
volume = "6",
pages = "919--926",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Neuroimaging of epilepsy, movement disorders, and degenerative diseases

AU - Murman, D. L.

AU - Frey, K. A.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Neuroimaging has improved the understanding, diagnosis, and management of several neurologic diseases and syndromes. Recent advances in the neuroimaging of epilepsy, movement disorders, and degenerative diseases of the nervous system are reviewed. Current research confirms that structural and functional neuroimages each provide unique, clinically useful information in these disorders. Quantification of images improves their diagnostic sensitivity and specificity. Presymptomatic or early neurochemical changes have been identified and followed longitudinally in several neurodegenerative diseases, providing a method for monitoring response to therapeutic intervention and pathophysiologic hypothesis testing. Functional activation studies and receptor-specific radioligands continue to advance our understanding of these disorders. Future methods will take increasing advantage of both the ability to measure neuropharmacological and neurochemical changes in vivo, and the ability to combine images and information obtained with distinct structural and functional neuroimaging modalities.

AB - Neuroimaging has improved the understanding, diagnosis, and management of several neurologic diseases and syndromes. Recent advances in the neuroimaging of epilepsy, movement disorders, and degenerative diseases of the nervous system are reviewed. Current research confirms that structural and functional neuroimages each provide unique, clinically useful information in these disorders. Quantification of images improves their diagnostic sensitivity and specificity. Presymptomatic or early neurochemical changes have been identified and followed longitudinally in several neurodegenerative diseases, providing a method for monitoring response to therapeutic intervention and pathophysiologic hypothesis testing. Functional activation studies and receptor-specific radioligands continue to advance our understanding of these disorders. Future methods will take increasing advantage of both the ability to measure neuropharmacological and neurochemical changes in vivo, and the ability to combine images and information obtained with distinct structural and functional neuroimaging modalities.

UR - http://www.scopus.com/inward/record.url?scp=0027379949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027379949&partnerID=8YFLogxK

U2 - 10.1097/00019052-199312000-00015

DO - 10.1097/00019052-199312000-00015

M3 - Review article

C2 - 7904884

AN - SCOPUS:0027379949

VL - 6

SP - 919

EP - 926

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 6

ER -